Annual CFI
$165.00 M
+$276.38 M+248.13%
December 31, 2024
Summary
- As of March 12, 2025, XENE annual cash flow from investing activities is $165.00 million, with the most recent change of +$276.38 million (+248.13%) on December 31, 2024.
- During the last 3 years, XENE annual CFI has risen by +$411.77 million (+166.86%).
- XENE annual CFI is now at all-time high.
Performance
XENE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$98.50 M
+$96.52 M+4874.90%
December 31, 2024
Summary
- As of March 12, 2025, XENE quarterly cash flow from investing activities is $98.50 million, with the most recent change of +$96.52 million (+4874.90%) on December 31, 2024.
- Over the past year, XENE quarterly CFI has stayed the same.
- XENE quarterly CFI is now -11.03% below its all-time high of $110.72 million, reached on June 30, 2024.
Performance
XENE Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$165.00 M
+$338.29 M+195.21%
December 31, 2024
Summary
- As of March 12, 2025, XENE TTM cash flow from investing activities is $165.00 million, with the most recent change of +$338.29 million (+195.21%) on December 31, 2024.
- Over the past year, XENE TTM CFI has stayed the same.
- XENE TTM CFI is now at all-time high.
Performance
XENE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
XENE Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +248.1% | 0.0% | 0.0% |
| 3 y3 years | +166.9% | +301.5% | +168.6% |
| 5 y5 years | +349.2% | +301.5% | +168.6% |
XENE Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +156.2% | -11.0% | +141.1% | at high | +133.2% |
| 5 y | 5-year | at high | +156.2% | -11.0% | +141.1% | at high | +133.2% |
| alltime | all time | at high | +156.2% | -11.0% | +141.1% | at high | +133.2% |
Xenon Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $165.00 M(-248.1%) | $98.50 M(+4874.9%) | $165.00 M(-195.2%) |
| Sep 2024 | - | $1.98 M(-98.2%) | -$173.29 M(+42.8%) |
| Jun 2024 | - | $110.72 M(-339.6%) | -$121.39 M(-40.6%) |
| Mar 2024 | - | -$46.20 M(-80.7%) | -$204.21 M(+83.3%) |
| Dec 2023 | -$111.39 M(-62.0%) | -$239.79 M(-545.0%) | -$111.39 M(-195.5%) |
| Sep 2023 | - | $53.88 M(+93.1%) | $116.67 M(-168.1%) |
| Jun 2023 | - | $27.90 M(-40.2%) | -$171.31 M(-13.4%) |
| Mar 2023 | - | $46.62 M(-497.2%) | -$197.90 M(-32.6%) |
| Dec 2022 | -$293.40 M(+18.9%) | -$11.74 M(-95.0%) | -$293.40 M(-41.0%) |
| Sep 2022 | - | -$234.10 M(<-9900.0%) | -$497.10 M(+100.9%) |
| Jun 2022 | - | $1.32 M(-102.7%) | -$247.43 M(+2.9%) |
| Mar 2022 | - | -$48.89 M(-77.3%) | -$240.55 M(-2.5%) |
| Dec 2021 | -$246.77 M(+1366.8%) | -$215.43 M(-1483.2%) | -$246.77 M(-2180.3%) |
| Sep 2021 | - | $15.57 M(+90.1%) | $11.86 M(-154.6%) |
| Jun 2021 | - | $8.19 M(-114.9%) | -$21.75 M(+14.4%) |
| Mar 2021 | - | -$55.10 M(-227.6%) | -$19.00 M(+13.0%) |
| Dec 2020 | -$16.82 M(-74.6%) | $43.20 M(-339.6%) | -$16.82 M(-86.0%) |
| Sep 2020 | - | -$18.03 M(-264.9%) | -$120.34 M(+27.3%) |
| Jun 2020 | - | $10.93 M(-120.7%) | -$94.57 M(-15.7%) |
| Mar 2020 | - | -$52.92 M(-12.3%) | -$112.13 M(+69.4%) |
| Dec 2019 | -$66.21 M | -$60.32 M(-879.3%) | -$66.21 M(+258.9%) |
| Sep 2019 | - | $7.74 M(-216.8%) | -$18.45 M(-62.8%) |
| Jun 2019 | - | -$6.63 M(-5.4%) | -$49.53 M(+20.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$7.00 M(-44.2%) | -$40.97 M(+41.3%) |
| Dec 2018 | -$28.99 M(-219.3%) | -$12.56 M(-46.2%) | -$28.99 M(+172.7%) |
| Sep 2018 | - | -$23.35 M(-1303.5%) | -$10.63 M(-184.1%) |
| Jun 2018 | - | $1.94 M(-61.0%) | $12.63 M(-36.9%) |
| Mar 2018 | - | $4.98 M(-14.2%) | $20.02 M(-17.6%) |
| Dec 2017 | $24.29 M(-150.8%) | $5.80 M(-6620.2%) | $24.29 M(-276.9%) |
| Sep 2017 | - | -$89.00 K(-101.0%) | -$13.73 M(-0.2%) |
| Jun 2017 | - | $9.33 M(+0.9%) | -$13.76 M(-64.3%) |
| Mar 2017 | - | $9.25 M(-128.7%) | -$38.51 M(-19.5%) |
| Dec 2016 | -$47.84 M(-569.3%) | -$32.23 M(>+9900.0%) | -$47.84 M(+203.6%) |
| Sep 2016 | - | -$111.00 K(-99.3%) | -$15.76 M(+127.1%) |
| Jun 2016 | - | -$15.42 M(>+9900.0%) | -$6.94 M(-180.5%) |
| Mar 2016 | - | -$83.00 K(-42.0%) | $8.62 M(-15.4%) |
| Dec 2015 | $10.19 M(-414.2%) | -$143.00 K(-101.6%) | $10.19 M(-10.4%) |
| Sep 2015 | - | $8.71 M(+6256.9%) | $11.38 M(-515.1%) |
| Jun 2015 | - | $137.00 K(-90.8%) | -$2.74 M(+93.7%) |
| Mar 2015 | - | $1.49 M(+43.4%) | -$1.42 M(-56.4%) |
| Dec 2014 | -$3.24 M(-71.7%) | $1.04 M(-119.2%) | -$3.24 M(-24.3%) |
| Sep 2014 | - | -$5.41 M(-469.7%) | -$4.28 M(-480.8%) |
| Jun 2014 | - | $1.46 M(-532.8%) | $1.13 M(-432.8%) |
| Mar 2014 | - | -$338.00 K | -$338.00 K |
| Dec 2013 | -$11.47 M(-2436.5%) | - | - |
| Dec 2012 | $491.00 K(-96.5%) | - | - |
| Dec 2011 | $13.89 M | - | - |
FAQ
- What is Xenon Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual CFI year-on-year change?
- What is Xenon Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly CFI year-on-year change?
- What is Xenon Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals TTM CFI year-on-year change?
What is Xenon Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of XENE is $165.00 M
What is the all time high annual CFI for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual cash flow from investing activities is $165.00 M
What is Xenon Pharmaceuticals annual CFI year-on-year change?
Over the past year, XENE annual cash flow from investing activities has changed by +$276.38 M (+248.13%)
What is Xenon Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of XENE is $98.50 M
What is the all time high quarterly CFI for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly cash flow from investing activities is $110.72 M
What is Xenon Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, XENE quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Xenon Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of XENE is $165.00 M
What is the all time high TTM CFI for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM cash flow from investing activities is $165.00 M
What is Xenon Pharmaceuticals TTM CFI year-on-year change?
Over the past year, XENE TTM cash flow from investing activities has changed by $0.00 (0.00%)